Microbot Medical targets $4M in 2026 revenue with the LIBERTY robotic system launch and a $1.9 price target after its capital raise. See why MBOT stock is a hold.

Microbot Medical Inc. announces a direct offering of common stock and a concurrent private placement, raising approximately $13 million. Microbot Medical Inc. announced a registered direct offering ...

Limited Market Release (LMR) of the LIBERTY® System is on Schedule Building on Positive Customer Feedback and Growing Market ...

HINGHAM, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), announced that Harel Gadot, Chairman, President and CEO, will be presenting at the H.C. Wainwright 24th Annual Global ...

Microbot Medical Inc. has appointed Ms. Michal Ahuvia as the new Director of Operations to enhance production and efficiency ahead of the commercial launch of their LIBERTY® Endovascular Robotic ...

Microbot Medical Inc. (MBOT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

HINGHAM, Mass., June 14, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical ...

Microbot Medical Inc. (MBOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

BRAINTREE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Robotic Surgical System, today announces additional updates regarding ...

BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market under ...

The MarketWatch News Department was not involved in the creation of this content. HINGHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of ...

Microbot Medical Inc (NASDAQ:MBOT) shares are trading higher by 22% to $2.58 during Monday’s session after the company announced it sold 4.26 million shares under an ATM agreement and generated $4.82 ...